Comparison

Sitagliptin European Partner

€39.00
Excl. VAT
Item no. TMO-T0242-50mg
Manufacturer TargetMol
CASRN 486460-32-6
Amount 50mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles C(=O)(C[C@@H](Cc1c(cc(c(c1)F)F)F)N)N1Cc2n(CC1)c(nn2)C(F)(F)F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Sitagliptin, MK-431; MK431; MK 431, DPP-4 inhibitor, MK0431
Similar products 486460-32-6
Available
Short Description
Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or in combination with metformin or thiazolidinedione for treatment of type 2 diabetes mellitus. The drug can competitively inhibit a protein/enzyme and DPP-4, that leads to an incremental amount of active incretins (GLP-1 and GIP), the diminished amount of release of glucagon and increased release of insulin.
Shipping
cool pack
Storage
-20°
Target names or alias
MK0431
Molecular Weight
407, 32
Pathway
Proteases/Proteasome|||Ubiquitination|||Autophagy
Target
Proteasome|||DPP-4|||Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
Listprice: €39.00
Price: €39.00
available

Delivery expected until 8/21/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close